aflofarm farmacja polska sp. z o.o

What aflofarm farmacja polska sp. z o.o does

Aflofarm Farmacja Polska Sp. z o.o. is a privately held Polish pharmaceutical company founded in 1989 and headquartered at ul. Partyzancka 133/151, Pabianice, Poland. The company develops, manufactures, and distributes more than 180 product brands spanning prescription (RX) and over-the-counter (OTC) medicines, medical devices, cosmetics, and dietary supplements. Since 2012, Aflofarm has held the #1 position in Poland's OTC pharmaceutical market, anchored by flagship brands Desmoxan (cytisine-based smoking cessation), Neosine (inosine pranobex antiviral/immunostimulant), Dafurag (furazidine-based UTI antibacterial), and Valerin (valerian-based sedatives), with additional franchises across respiratory (Envil, Flegafortan), pain/inflammation (Opokan meloxicam line), venous health (Rostil), allergy (Duozinal), and pediatric care (Envil cough junior, Kidofen max). All products are manufactured on GMP-certified (Good Manufacturing Practice) lines and the company exports to 31 countries across Central, Eastern, and Western Europe, North America, the Middle East, the Caucasus, Central Asia, and Southeast Asia.

The company employs more than 1,500 people, including pharmacists, physicians, biotechnologists, technologists, and marketers working across laboratories, offices, production facilities, warehouses, and field operations. Revenue is generated through one-time product sales of pharmaceutical and consumer health products distributed via pharmacy retail channels in Poland and via export partnerships internationally, with a horizontally segmented customer base of individual end-consumers. Marketing channels combine celebrity endorsements (notably Aneta Zając as ambassador for Iladian 40+), social media presence (LinkedIn, Facebook), content marketing via the corporate website, and event-based recruitment (CHeMoLuBNi student conference). R&D activity has been partially supported by EU Regional Operational Programme co-financing under the Łódź Voivodeship 2014-2020 framework, with a 9,973,254 PLN project value and 2,838,430 PLN EU contribution for pharmaceutical research infrastructure.

Aflofarm operates as a Polish sp. z o.o. private limited company with no disclosed external institutional investors, no public listing, and a registered share capital of 26,271,500 PLN per KRS filing 0000014115. The company is affiliated with two nonprofit foundations: Fundacja Aflofarm (health promotion) and Fundacja My Kochamy Pabianice (community development for the host city). Recent strategic activity includes the 2026-07-23 launch of Iladian 40+ in new packaging with pump dispenser, the 2026-07-14 relaunch of the AfloSTART internship program for pharmaceutical and biotechnology students, and ongoing R&D infrastructure investment supported by EU funds.

Name

aflofarm farmacja polska sp. z o.o

Legal name

Aflofarm Farmacja Polska Sp. z o. o.

Website

https://aflofarm.pl

Company type

Private

Founded year

1989

Operating status

Operating

Short description

Aflofarm Farmacja Polska is a privately held Polish pharmaceutical manufacturer and Poland's #1 OTC brand since 2012, producing 180+ prescription, OTC, medical device, cosmetic, and dietary supplement products exported to 31 countries.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

Keywords

• Pharmaceutical manufacturing
• OTC medicines
• Prescription drugs
• Medical devices
• Dietary supplements

Headquarters

HQ city

Pabianice

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical product sales: Aflofarm generates revenue through the sale of pharmaceutical products including prescription drugs (RX), over-the-counter medicines (OTC), medical devices, cosmetics, and dietary supplements. The company has a broad portfolio of over 180 product brands and operates as the market leader in Poland's OTC pharmaceutical segment since 2012.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Aflofarm develops, manufactures, and distributes a broad portfolio of pharmaceutical and healthcare products including prescription drugs (RX), over-the-counter medicines (OTC), medical devices, cosmetics, and dietary supplements. The company operates GMP-certified manufacturing facilities and markets 180+ product brands through pharmacies in Poland and exports to 31 countries worldwide.

Product overview

Aflofarm Farmacja Polska is Poland's #1 pharmaceutical company in the OTC market, operating since 1989 with over 180 product brands. The company offers a comprehensive portfolio spanning prescription medications (RX), over-the-counter drugs (OTC), medical devices, cosmetics, and dietary supplements. Key product lines include Neosine (antiviral/immunostimulant with inosine pranobex), Valerin (herbal sedatives with valerian), Opokan (NSAID meloxicam products), Dafurag max (urinary tract antibacterial), Desmoxan (smoking cessation with cytisine), and various respiratory products like Flegafortan (bromohexine for expectoration) and Envil (throat/cough treatments). The company also produces dermatological products, venous medications (Rostil), allergy treatments (Duozinal), and weight management devices (Calominal duo). Products are manufactured according to GMP standards and exported to 31 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Desmoxan: Smoking cessation product - a 25-day treatment for weaning off smoking containing cytisine.
• Neosine
• Dafurag
• Valerin
• Valerin max
• FluControl
• Diohespan
• Opokan
• Envil
• EU-Funded R&D Projects
• Iladian

Products and services

• Desmoxan tablets Over-the-counter smoking cessation medication containing 1.5 mg cytisine per tablet. A full 25-day treatment that helps gradually reduce nicotine addiction by displacing nicotine from the body, allowing users to quit smoking within the first days of treatment.
• Neosine Antiviral and immunostimulating medicine containing inosine pranobex, indicated for people with weakened immunity and recurrent upper respiratory infections, and inhibits herpes virus multiplication.
• Neosine forte Double-dose version of Neosine with 1000 mg inosine pranobex per tablet. Available in tablet and syrup forms, including for children from 1 year of age (syrup).
• Neosine duo Prescription medication combining inosine pranobex with zinc gluconate. Available in tablet (10 or 30 tablets) and syrup (150 ml) forms.
• Valerin Herbal sedative medicine containing 200 mg valerian root dry extract per tablet, indicated for mild nervous tension, anxiety, and sleep problems.
• Valerin max Maximum-dose valerian product containing 360 mg valerian root dry extract per tablet - the highest available dose. Indicated for mild nervous tension and anxiety conditions.
• Valerin sen (sleep) Food supplement containing lemon balm, hops extract, L-theanine, L-tryptophan, GABA, saffron extract, vitamin B6, and magnesium. Helps relax and calm the body, facilitating falling asleep and improving sleep quality.
• Valerin sen z melatoniną (sleep with melatonin) Food supplement with melatonin (1 mg per 2 tablets) combined with hop cones, chamomile, and lemon balm extracts. Supports falling asleep faster and ensures restful overnight sleep.
• Opokan NSAID containing 7.5 mg meloxicam per tablet. Used as analgesic and anti-inflammatory drug for bone, joint, and muscle pain. Relieves pain for up to 24 hours with a single tablet.
• Opokan-forte Prescription-strength meloxicam tablets for aggravated rheumatic diseases including rheumatoid arthritis, juvenile rheumatoid arthritis, and ankylosing spondylitis.
• Opokan FAST Solution for injection containing 15 mg/1.5 ml meloxicam. Prescription medication for acute pain relief.
• Opokan-keto gel Prescription topical ketoprofen gel (50 g or 100 ml) for pain relief and anti-inflammatory treatment.
• Opokan med Self-heating therapeutic patches producing soothing warmth (approximately 50°C) that relaxes tense muscles, relieves pain, reduces inflammation, and provides relief. Single-use patches lasting up to 12 hours.
• Dafurag max Antibacterial medication for lower urinary tract infections containing maximum dose of furazidine (100 mg per tablet). Also known as furagin, suppresses bacteria causing urinary tract infections.
• Duozinal Anti-allergic syrup containing 2.5 mg cetirizine dihydrochloride and 58 mg calcium ions per 5 ml. Reduces nose and eye symptoms of seasonal and chronic allergic rhinitis, and symptoms of chronic idiopathic urticaria.
• Flegafortan 0.8 mg/ml Syrup (125 ml) containing 0.8 mg/ml bromohexine hydrochloride. Treats chronic and acute airway diseases with difficult expectoration of thick bronchial secretions.
• Flegafortan 1.6 mg/ml Syrup (200 ml) with highest concentration of bromohexine hydrochloride (1.6 mg/ml) available on market. Thins mucus, clears bronchial passages, and facilitates expectoration.
• Envil cough junior syrup Syrup containing 15 mg ambroxol hydrochloride per 5 ml. Helps loosen and expectorate airway secretions in children from 1 year of age.
• Calominal duo Weight management powder containing glucomannan and chitosan that binds lipids and carbohydrates. Reduces fats and sugars absorbed from food, increases satiety, and supports body weight reduction.
• Aflofarm Ichthyol Ointment Topical ointment containing 0.1 g ichthammol per gram. Indicated for eczema, furunculosis, and acne with bacteriostatic effect and ability to facilitate drainage of pus.
• Aflofarm Marjoram Ointment Topical ointment for nasal mucosa inflammation (catarrh) containing marjoram herb extract.
• Envil throat lozenges Antiseptic and local anesthetic lozenges containing cetylpyridinium chloride (1.5 mg), lidocaine hydrochloride (1.0 mg), and zinc gluconate (17.42 mg). For throat and mouth inflammations.
• Dezaftan med oral spray Antiseptic and local anesthetic spray (30 ml) containing cetylpyridinium chloride, lidocaine, and zinc gluconate. Provides relief within 1 minute for oral inflammations, gingivitis, and aphthae.
• STEPER PRO cream Antifungal foot cream containing 10 mg bifonazole per gram. Broad-spectrum antifungal activity for treatment of skin fungal infections including hands, feet, ringworm, and jock itch.

Quantifiable outcome

• Market leader in Polish OTC pharmaceutical market since 2012
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature1 record

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Regional players

• KRKA: Slovenian generic and OTC pharmaceutical manufacturer with strong Central/Eastern European presence and broad international export footprint. Comparable mid-size European pharma with focus on affordable medicines and OTC expansion.
• Gedeon Richter: Hungarian pharmaceutical company with strong Central/Eastern European OTC and women's health franchises, exporting globally. Comparable European OTC scale, therapeutic portfolio breadth, and geographic reach from a neighboring CEE market.
• Berlin-Chemie (Menarini Group): German pharmaceutical company within Menarini Group with strong OTC and prescription drug portfolio focused on Central/Eastern European markets. Comparable in CEE market emphasis, OTC breadth, and multi-country distribution.

Direct peers

• Polpharma: Poland's largest pharmaceutical manufacturer offering RX, OTC, and consumer health products with significant domestic market share. Most direct comparable to Aflofarm given similar Polish base, OTC leadership position, broad therapeutic portfolio, and export activities.
• USP Zdrowie (Pelion Group): Polish pharmaceutical manufacturer and part of Pelion healthcare group, offering OTC, RX, dietary supplements, and medical devices with strong domestic distribution. Direct competitor to Aflofarm in Polish OTC and consumer health categories.

Broad incumbents

• STADA Arzneimittel: German-headquartered European generics and OTC pharmaceutical company with broad portfolio across consumer health, generics, and specialty. Comparable in OTC focus, multi-country European distribution, and branded generic strategy.
• Viatris: Global pharmaceutical company formed from Mylan-Upjohn merger with strong generic, OTC, and consumer health presence across multiple continents. Comparable in OTC consumer health portfolio breadth, international distribution, and post-merger integration strategy.
• Teva Pharmaceutical Industries: Global leader in generic pharmaceuticals with significant OTC business and broad geographic footprint. Comparable in OTC generics portfolio, international distribution scale, and manufacturing integration, though much larger.
• Zentiva: Czech-based European generic and OTC pharmaceutical manufacturer with operations across Europe. Comparable in OTC portfolio breadth and European market focus, though larger and backed by Advent International.
• Sandoz (Novartis): Global generics and biosimilars leader spun off from Novartis with strong European presence and OTC portfolio. Comparable in pharmaceutical manufacturing scale, European OTC footprint, and regulatory/manufacturing capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/postroniezdrowia
• LinkedInlinkedin.com/company/aflofarm-farmacja-polska-sp-z-o-o

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about aflofarm farmacja polska sp. z o.o